Cache-Control:s-maxage=0 Access-Control-Allow-Origin: * Strict-Transport-Security: max-age=31536000 X-Frame-Options:* Permissions-Policy: geolocation=*, autoplay=*, encrypted-media=*, fullscreen=* Referrer-Policy: no-referrer-when-downgrade, strict-origin-when-cross-origin Strict-Transport-Security: max-age=31536000 X-Content-Type-Options: nosniff X-Frame-Options:* Content-type: text/html; charset=utf-8 Amphastar Pharmaceuticals, Inc. - Home
Investor Relations

Company Profile

Amphastar is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the Company sells insulin API products. Most of the Company’s finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers.

Company News

30Apr 2024

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024

More
01Apr 2024

Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference

More

Financial Calendar

08May 2024

Amphastar First Quarter Earnings Call

Add to Calendar

Email Alert

Subscribe to our newsletter

Spam protection: Please accept and solve the Captcha if prompted.
Youtube